在体外循环心脏手术中应用抑肽酶对机体的保护作用
The protective effect of aprotinin in patients undergoing cardiopulmonary bypass cardiac surgery
出处
《武警医学院学报》
CAS
2004年第3期254-256,共3页
Acta Academiae Medicinae CPAPF
参考文献19
-
1[1]Peter DC,Noble S.Aprotinin an update of its pharmacology and therapeutic use in open heart and coronary artery bypass surgery[J].Drug,1999,57(2):233-259.
-
2[2]Ray MJ,Marsh NA.Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin[J].Thomb Haemost,1997,78:1021-1026.
-
3[3]Despotis GJ,Joist JH.Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass:an update[J].J Cardiothorac Vasc Anesth,1999,13(4):18-29.
-
4[4]Dery O,Corvera CU,Steinhoff M,et al.Proteinase-activated receptors:novel mechanisms of signaling by serine proteases[J].Am J Physiol,1998,274:1429-1452.
-
5[5]Diego RP,Mihalakakos PJ,Hexum TD,et al.Methylprednisolone and full-dose aprotinin reduce reperfusion injury after cardiopulmonary bypass[J].J Cardiothorac Vasc Anesth,1997,11:29-31.
-
6[7]Absence of beneficial effect of acute normovolemic hemodilution combined with aprotinin on allogeneic blood transfusion requirements in cardiac surgery[J].Anesthesiology,2002,96:276-282.
-
7[8]Despotis GJ,Gravlee G,Filos K,et al.Anticoagulation monitoring during cardiac surgery-a review of current and emerging techniques[J].Anesthesiology,1999,91(4):1122-1151.
-
8[9]Lars EN,Beat KI,Pascal A,et al.Aprotinin in coronary operation with cardiopul monary bypass:"low-dose"aprotinin inhibit the inflammatory response?[J] Ann Thorac Surg,2002,73:1897-1904.
-
9[10]Hans ME,Wulf DI,Siegmund LB,et al.High-dose aprotinin reduces activation of hemostasis,allogeneic blood requirement,and duration of postoperative ventilation in pediatric cardiac surgery[J].Ann Thorac Surg,2003,75:430-437.
-
10[11]Rebecca J,David W,Peng W,et al.Ultra-low dose aprotinin decreases transfusion requirements and is cost effective in coronary operations[J].Ann Thorac Surg,2001,71,158-164.
-
1郭玉梅.亚低温血液滤过治疗对重症颅脑损伤患者脏器的保护作用研究[J].中国当代医药,2017,24(2):20-22. 被引量：2
-
2古旭云,陈炜,王锁柱,张静姝,陆非平,刘龙.血必净注射液对多器官功能障碍综合征患者脏器保护作用的研究[J].中国现代医药杂志,2009,11(4):28-30. 被引量：6
-
3梁小仲,姚华国,张媛莉.乌司他丁在脓毒症时脏器保护作用的研究进展[J].医学综述,2006,12(16):1008-1010. 被引量：5
-
4李民仕.早期应用乌司他丁对中重度烧伤患者的脏器保护作用[J].海南医学,2012,23(2):43-45. 被引量：8
-
5尚游,姚尚龙,袁世荧.高渗溶液与粘附分子[J].国外医学（麻醉学与复苏分册）,2003,24(5):275-277.
-
6李皓.雷米普利黄芪治疗糖尿病肾病疗效观察[J].现代中西医结合杂志,2002,11(4):300-301.
-
7朱月文.慢性肾功能衰竭患者CD62P表达与肾功能的关系[J].浙江临床医学,2006,8(6):597-598.
-
8王显悦,董文鹏,童光,毕生辉,张本,陆华,王晓武,张卫达.大剂量乌司他丁对A型主动脉夹层全弓置换患者的脏器保护作用[J].南方医科大学学报,2016,36(8):1085-1089. 被引量：11
-
9王金龙,王其敏,王孝东.小儿室间隔缺损修补术后残余漏的防治[J].医药论坛杂志,2007,28(2):103-103.
-
10鲍舟君,姚燕珍,赵志钧,张国梁.一氧化氮和内皮素在糖尿病肾病患者中的变化[J].实验与检验医学,2008,26(3):325-325. 被引量：1
